Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials

Table 1 Data from 14 trials on intravenous chemotherapy vs surgery alone after resection for gastric cancer

Author	Published time	Chemotherapy regimens	Chemotherapy group (number of death/total)	Surgery group (number of death/total)	Follow -uptime (months)
Lise	1995	FAM	88/163	99/163	78
Hallissey	1994	FAM	101/138	110/145	60
Estape	1991	MMC	16/33	31/37	120
Kim	1992	FM	54/77	71/94	60
Li LJ	1994	MFV/MFC/FAM	167/308	282/341	60
Wang BD	1994	FM+Ara-C	49/78	36/42	36
Li HX	1994	FM	182/208	192/213	60
Coombes	1998	FEM	36/42	38/42	60
Schlag	1987	5Fu + BCNU	21/42	28/53	72
Neri	1996	Epidoxorubicin	36/48	48/55	36
Zhou GX	1998	FM	35/41	38/40	60
Lawton	1981	5Fu + BCNU	11/13	10/12	60
Cirera	1999	MMC + Tegafur	33/76	44/72	37
Hermans	1993	Meta-analysis	720/1098	588/869	NA

Abbreviations: F/5-Fu, fluorouracil; A,doxorubicin; M/MMC, mitomycin; C/Ara-C,cytarabine; E,etoposide; V,vinblastine; BCNU,1,3-bis-(2-chloroethyl)-1-(nitrosourea); NA,no available.